Financhill
Buy
70

NU Quote, Financials, Valuation and Earnings

Last price:
$12.24
Seasonality move :
18.61%
Day range:
$12.01 - $12.43
52-week range:
$9.01 - $16.15
Dividend yield:
0%
P/E ratio:
27.52x
P/S ratio:
6.93x
P/B ratio:
6.78x
Volume:
51.4M
Avg. volume:
56.2M
1-year change:
2.28%
Market cap:
$58.4B
Revenue:
$8.3B
EPS (TTM):
$0.44
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $359.9M $1.1B $3B $5.6B $8.3B
Revenue Growth (YoY) 0.11% 218.19% 159.45% 89.56% 46.83%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $264.5M $659.9M $1.4B $1.1B $1.4B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $272M $677.2M $1.5B $1.2B $1.5B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$193.2M -$170.2M -$308.9M $1.5B $2.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$21.7M -$4.8M $55.7M $508.5M $823.1M
Net Income to Company -$171.5M -$165.3M -$364.6B $1B $2B
 
Minority Interest in Earnings -- $341K $56K -- --
Net Income to Common Excl Extra Items -$171.5M -$165M -$364.6M $1B $2B
 
Basic EPS (Cont. Ops) -$0.04 -$0.10 -$0.08 $0.22 $0.41
Diluted EPS (Cont. Ops) -$0.04 -$0.10 -$0.08 $0.21 $0.40
Weighted Average Basic Share $4.6B $1.6B $4.7B $4.7B $4.8B
Weighted Average Diluted Share $4.6B $1.6B $4.7B $4.9B $4.9B
 
EBITDA -- -- -- -- --
EBIT $21.9M $197.2M $1.2B $3.6B $5.6B
 
Revenue (Reported) $359.9M $1.1B $3B $5.6B $8.3B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $21.9M $197.2M $1.2B $3.6B $5.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $173.5M $547.3M $1.1B $2B $2.3B
Revenue Growth (YoY) -- 215.49% 101.54% 79.32% 13.77%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $111.4M $256.7M $248.1M $362.6M $311.4M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $113.9M $264.4M $261.3M $381.1M $332.7M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$53.4M -$67.7M $243.6M $578.5M $795.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$3.9M -$22.6M $101.9M $199.7M $237.9M
Net Income to Company -$49.5M -$45M $141.8M $378.8M $557.2M
 
Minority Interest in Earnings -- -$97K -- -- -$5K
Net Income to Common Excl Extra Items -$49.5M -$45.1M $141.8M $378.8M $557.2M
 
Basic EPS (Cont. Ops) -$0.01 -$0.01 $0.03 $0.08 $0.12
Diluted EPS (Cont. Ops) -$0.01 -$0.01 $0.03 $0.08 $0.11
Weighted Average Basic Share $4.6B $4.7B $4.7B $4.8B $4.8B
Weighted Average Diluted Share $4.6B $4.7B $4.8B $4.9B $4.9B
 
EBITDA -- -- -- -- --
EBIT -$21.6M $205.4M $683.8M $1.2B $1.7B
 
Revenue (Reported) $173.5M $547.3M $1.1B $2B $2.3B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -$21.6M $205.4M $683.8M $1.2B $1.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- $1.5B $3.5B $6.5B $8.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $805.2M $1.4B $1.3B $1.4B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- $827.7M $1.5B $1.3B $1.5B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -$184.4M $2.4M $1.9B $3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$23.6M $180.3M $606.4M $861.2M
Net Income to Company -- -$160.9M -$364.4B $1.3B $2.2B
 
Minority Interest in Earnings -- $244K $153K -- -$5K
Net Income to Common Excl Extra Items -- -$160.6M -$177.7M $1.3B $2.2B
 
Basic EPS (Cont. Ops) -- -$0.03 -$0.04 $0.27 $0.45
Diluted EPS (Cont. Ops) -- -$0.03 -$0.04 $0.26 $0.44
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT -- $424.2M $1.7B $4.1B $6.1B
 
Revenue (Reported) -- $1.5B $3.5B $6.5B $8.5B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- $424.2M $1.7B $4.1B $6.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $173.5M $547.3M $1.1B $2B $2.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $111.4M $256.7M $248.1M $362.6M $311.4M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $113.9M $264.4M $261.3M $381.1M $332.7M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$53.4M -$67.7M $243.6M $578.5M $795.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$3.9M -$22.6M $101.9M $199.7M $237.9M
Net Income to Company -$49.5M -$45M $141.8M $378.8M $557.2M
 
Minority Interest in Earnings -- -$97K -- -- -$5K
Net Income to Common Excl Extra Items -$49.5M -$45.1M $141.8M $378.8M $557.2M
 
Basic EPS (Cont. Ops) -$0.01 -$0.01 $0.03 $0.08 $0.12
Diluted EPS (Cont. Ops) -$0.01 -$0.01 $0.03 $0.08 $0.11
Weighted Average Basic Share $4.6B $4.7B $4.7B $4.8B $4.8B
Weighted Average Diluted Share $4.6B $4.7B $4.8B $4.9B $4.9B
 
EBITDA -- -- -- -- --
EBIT -$21.6M $205.4M $683.8M $1.2B $1.7B
 
Revenue (Reported) $173.5M $547.3M $1.1B $2B $2.3B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -$21.6M $205.4M $683.8M $1.2B $1.7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $603.3M $2.5B $6.9B $13.4B $13.6B
Short Term Investments -- $8.2B $9.9B $8.7B $9.5B
Accounts Receivable, Net $2.9B $4.8B $8.2B $12.4B $12.3B
Inventory -- -- -- -- --
Prepaid Expenses $18.5M $39.9M $84.4M $178.1M $153.1M
Other Current Assets -- -- -- -- --
Total Current Assets $5.3B $16.9B $26B $36.8B $39.6B
 
Property Plant And Equipment $20.5M $20.5M $46.5M $69.8M $46.2M
Long-Term Investments $4.3B $9B $10.5B $9.3B $11.2B
Goodwill $831K $401.9M $397.4M $397.5M $414.3M
Other Intangibles $12.4M $72.3M $182.2M $295.9M $347.6M
Other Long-Term Assets -- -- -- -- --
Total Assets $10.2B $19.9B $29.9B $43.3B $49.9B
 
Accounts Payable $3.3B $4.9B $7.1B $9.8B $9.3B
Accrued Expenses $25.8M $97.9M $90.6M $166.9M $180.2M
Current Portion Of Long-Term Debt -- -- $38.3M $113.6M $222.9M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.4B $5.2B $8B $11.7B $11.4B
 
Long-Term Debt $177.2M $157.3M $547.2M $806.7M $328.9M
Capital Leases -- -- -- -- --
Total Liabilities $9.7B $15.4B $25B $36.9B $42.3B
 
Common Stock $45K $83K $83K $84K $84K
Other Common Equity Adj -$97.5M -$109.2M -$137.7M $156.4M -$828.2M
Common Equity $438.1M $4.4B $4.9B $6.4B $7.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $1.5M -- -- $787K
Total Equity $438.1M $4.4B $4.9B $6.4B $7.6B
 
Total Liabilities and Equity $10.2B $19.9B $29.9B $43.3B $49.9B
Cash and Short Terms $603.3M $10.7B $16.8B $22B $23.1B
Total Debt $177.2M $157.3M $585.6M $920.3M $551.8M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents -- $3.2B $6.9B $13B $14.9B
Short Term Investments -- $9.3B $7.9B $8.8B $9.4B
Accounts Receivable, Net -- $6.2B $9.2B $12.8B $13.5B
Inventory -- -- -- -- --
Prepaid Expenses -- $75.1M $94.5M $210.9M $142.6M
Other Current Assets -- -- -- -- --
Total Current Assets -- $20.1B $25.4B $36.3B $42.4B
 
Property Plant And Equipment -- $37.2M $46.9M $65.5M $46.1M
Long-Term Investments -- $10.4B $8.1B $9.7B $10.5B
Goodwill -- $409.6M $397.5M $397.6M $408.8M
Other Intangibles -- $120.6M $215.3M $307.4M $439.8M
Other Long-Term Assets -- -- -- -- --
Total Assets -- $24.3B $29.5B $43.8B $54.2B
 
Accounts Payable -- $5.9B $6.9B $9.6B $10.1B
Accrued Expenses -- $115.6M $101.3M $191.5M $180.4M
Current Portion Of Long-Term Debt -- -- -- $97.9M $351.5M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $6.2B $7.4B $11B $11.9B
 
Long-Term Debt -- $147.6M $651.2M $820.3M --
Capital Leases -- -- -- -- --
Total Liabilities -- $19.5B $24.3B $37B $45.6B
 
Common Stock -- $83K $83K $84K $84K
Other Common Equity Adj -- -$54.8M -$14.4M $111.8M -$480.6M
Common Equity -- -- -- -- --
Total Preferred Equity $400M -- -- -- --
Minority Interest, Total -- $1.5M -- -- $1M
Total Equity -- $4.8B $5.2B $6.8B $8.6B
 
Total Liabilities and Equity -- $24.3B $29.5B $43.8B $54.2B
Cash and Short Terms -- $12.4B $14.9B $21.8B $24.3B
Total Debt -- $147.6M $651.2M $918.2M $351.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$171.5M -$165.3M -$364.6B $1B $2B
Depreciation & Amoritzation $7.4M $17.3M $35.6B $62.9M $77.1M
Stock-Based Compensation $35.6M $157.3M $253.2B $212.6M $272.4M
Change in Accounts Receivable -$470.2M -$2.6B -$5.7T -$9B -$5.5B
Change in Inventories -- -- -- -- --
Cash From Operations $974.5M -$2.9B $755.6B $1.3B $2.4B
 
Capital Expenditures $8M $28.5M $114.3B $177M $175M
Cash Acquisitions -$8.3M -$114.5M -$10.3B -- -$5.6M
Cash From Investing -$16.3M -$154.2M -$127.2B -$177M -$330.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $18M $116.3M $581.1B $469.5M $1.3B
Long-Term Debt Repaid -$84.6M -$131.3M -$175.6B -$53.4M -$587.7M
Repurchase of Common Stock -$15K -$4.6M -- -- --
Other Financing Activities -- -$47.5M -$4B -- --
Cash From Financing $240.1M $3.3B $654B $425.2M $727.7M
 
Beginning Cash (CF) $1.2B $2.3B $2.7T $4.2B $5.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B $257.5M $1.3T $1.5B $2.8B
Ending Cash (CF) $2.3B $2.7B $4.2T $5.9B $9.2B
 
Levered Free Cash Flow $966.5M -$3B $641.3B $1.1B $2.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$49.5M -$45M $141.8M $378.8M $557.2M
Depreciation & Amoritzation $2.5M $7.7M $13.2M $18.5M $21.3M
Stock-Based Compensation $32.2M $42.1M $57.9M $78.6M $77.8M
Change in Accounts Receivable -$608.6M -$1.6B -$2.1B -$1.5B -$2.2B
Change in Inventories -- -- -- -- --
Cash From Operations -$222.7M $78.3M $94.3M -$570.6M $1.1B
 
Capital Expenditures $5.2M $14.7M $46.5M $26.8M $82.5M
Cash Acquisitions -- -$10.3M -- -- --
Cash From Investing -$5.2M -$38.2M -$46.5M -$26.8M -$81.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $16.6M -- $19.7M $269.7M $187.2M
Long-Term Debt Repaid -$21.7M -$19.7M -$1.9M -$13.3M -$356.8M
Repurchase of Common Stock -$2M -- -- -- --
Other Financing Activities -- -$4M -- -- --
Cash From Financing $395.2M $225.6M $19.9M $258.2M -$169.2M
 
Beginning Cash (CF) $2.3B $2.7B $4.2B $5.9B $9.2B
Foreign Exchange Rate Adjustment -$310.4M -$2.8M $70.5M $449.4M $263.5M
Additions / Reductions $167.3M $265.7M $67.7M -$339.2M $834.8M
Ending Cash (CF) $2.2B $3B $4.3B $6B $10.3B
 
Levered Free Cash Flow -$227.9M $63.6M $47.8M -$597.4M $1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -$160.9M -$364.4B $1.3B $2.2B
Depreciation & Amoritzation -- $22.5M $35.6B $68.2M $80M
Stock-Based Compensation $32.2M $167.2M $253.2B $233.3M $271.5M
Change in Accounts Receivable -- -$3.5B -$5.7T -$8.3B -$6.3B
Change in Inventories -- -- -- -- --
Cash From Operations -- -$2.6B $755.6B $601.3M $4.1B
 
Capital Expenditures $5.2M $38M $114.3B $157.3M $230.7M
Cash Acquisitions -- -$124.8M -$10.3B -- -$5.6M
Cash From Investing -- -$187.2M -$127.2B -$157.3M -$385.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $99.8M $581.2B $719.5M $1.2B
Long-Term Debt Repaid -- -$129.3M -$175.6B -$64.9M -$931.2M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- $3.2B $653.8B $663.6M $300.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $355.9M $1.3T $1.1B $4B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -$2.7B $641.3B $444M $3.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$49.5M -$45M $141.8M $378.8M $557.2M
Depreciation & Amoritzation $2.5M $7.7M $13.2M $18.5M $21.3M
Stock-Based Compensation $32.2M $42.1M $57.9M $78.6M $77.8M
Change in Accounts Receivable -$608.6M -$1.6B -$2.1B -$1.5B -$2.2B
Change in Inventories -- -- -- -- --
Cash From Operations -$222.7M $78.3M $94.3M -$570.6M $1.1B
 
Capital Expenditures $5.2M $14.7M $46.5M $26.8M $82.5M
Cash Acquisitions -- -$10.3M -- -- --
Cash From Investing -$5.2M -$38.2M -$46.5M -$26.8M -$81.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $16.6M -- $19.7M $269.7M $187.2M
Long-Term Debt Repaid -$21.7M -$19.7M -$1.9M -$13.3M -$356.8M
Repurchase of Common Stock -$2M -- -- -- --
Other Financing Activities -- -$4M -- -- --
Cash From Financing $395.2M $225.6M $19.9M $258.2M -$169.2M
 
Beginning Cash (CF) $2.3B $2.7B $4.2B $5.9B $9.2B
Foreign Exchange Rate Adjustment -$310.4M -$2.8M $70.5M $449.4M $263.5M
Additions / Reductions $167.3M $265.7M $67.7M -$339.2M $834.8M
Ending Cash (CF) $2.2B $3B $4.3B $6B $10.3B
 
Levered Free Cash Flow -$227.9M $63.6M $47.8M -$597.4M $1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

AMC Stock Forecast, How High Could It Go in 2025 and Beyond?
AMC Stock Forecast, How High Could It Go in 2025 and Beyond?

AMC Entertainment (NYSE:AMC) has been rising lately after years of…

Where Will Reddit Stock Be In 5 Years?
Where Will Reddit Stock Be In 5 Years?

On a wet March morning last year, the famously orange…

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
47
RGC alert for Jun 18

Regencell Bioscience Holdings [RGC] is down 18.36% over the past day.

Sell
20
ENPH alert for Jun 18

Enphase Energy [ENPH] is up 4.18% over the past day.

Sell
49
QNTM alert for Jun 18

Quantum BioPharma [QNTM] is up 17.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock